Alpine Immune Sciences (ALPN) Earnings Date, Estimates & Call Transcripts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueALPN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ALPN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Alpine Immune Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20244($0.45)($0.38)($0.42)Q2 20244($0.46)($0.41)($0.44)Q3 20244($0.50)($0.44)($0.47)Q4 20244($0.53)($0.47)($0.49)FY 202416($1.94)($1.70)($1.81)Q1 20251($0.52)($0.52)($0.52)Q2 20251($0.53)($0.53)($0.53)Q3 20251($0.51)($0.51)($0.51)Q4 20251($0.52)($0.52)($0.52)FY 20254($2.08)($2.08)($2.08) Get Alpine Immune Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for ALPN and its competitors with MarketBeat's FREE daily newsletter. Alpine Immune Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks5/9/2024Q1 2024($0.43)($0.28)+$0.15($0.28)$5.50 million$7.03 million3/18/2024Q4 2023($0.32)$0.15+$0.47$0.15$6.90 million$30.85 million11/14/2023Q3 2023($0.35)($0.24)+$0.11($0.24)$8.73 million$10.04 million8/14/2023Q2 2023($0.38)($0.27)+$0.11($0.27)$8.08 million$8.59 million5/11/2023Q1 2023($0.37)($0.28)+$0.09($0.28)$8.60 million$9.39 million3/23/2023Q4 2022($0.27)($0.41)($0.14)($0.41)$10.42 million$2.78 million Get the Latest News and Ratings for ALPN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alpine Immune Sciences and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Q3 2022($0.10)($0.42)($0.32)($0.42)$20.43 million$8.37 million8/11/2022Q2 2022($0.39)($0.60)($0.21)($0.60)$8.64 million$5.29 million5/12/2022Q1 2022($0.17)($0.25)($0.08)($0.25)$13.35 million$13.63 million 3/17/2022Q4 2021($0.26)($0.52)($0.26)($0.52)$8.26 million$4.53 million11/9/2021Q3 2021$0.01($0.55)($0.56)($0.55)$22.30 million$8.52 million8/9/2021Q2 2021($0.29)($0.46)($0.17)($0.46)$6.59 million$7.19 million 5/12/2021Q1 2021($0.36)($0.45)($0.09)($0.45)$5.84 million$3.20 million 3/17/2021Q4 2020($0.31)($0.27)+$0.04($0.27)$2.80 million$5.64 million 11/17/2020Q3 2020($0.23)($0.28)($0.05)($0.28)$4.80 million$1.91 million 8/11/2020Q2 2020($0.23)($0.53)($0.30)($0.53)$2.13 million$0.69 million 5/14/2020Q1 2020($0.47)($0.30)+$0.17($0.30)$0.38 million$1.09 million 3/30/2020Q4 2019($0.55)($0.33)+$0.22($0.33)$0.28 million$0.88 million 11/13/2019Q3($0.68)($0.62)+$0.06($0.62)$0.38 million$0.29 million Alpine Immune Sciences Earnings - Frequently Asked Questions How much revenue does Alpine Immune Sciences generate each year? Alpine Immune Sciences (NASDAQ:ALPN) has a recorded annual revenue of $56.52 million. How much profit does Alpine Immune Sciences generate each year? Alpine Immune Sciences (NASDAQ:ALPN) has a recorded net income of -$32.18 million. ALPN has generated -$0.64 earnings per share over the last four quarters. What is Alpine Immune Sciences's EPS forecast for next year? Alpine Immune Sciences's earnings are expected to decrease from ($1.74) per share to ($1.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies: XNCR Earnings ZYME Earnings HARP Earnings MGNX Earnings ASMB Earnings PIRS Earnings BMRN Earnings RPRX Earnings UTHR Earnings VTRS Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Is Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 EarningsNVIDIA: Analysts Bullish Ahead of Earnings - Is It a Buy Now? This page (NASDAQ:ALPN) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpine Immune Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpine Immune Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
